Published in Nihon Hinyokika Gakkai Zasshi on October 01, 1977
Intravesical adriamycin chemotherapy in bladder cancer. Cancer Chemother Pharmacol (1983) 1.02
Intravesical instillation of adriamycin in the presence or absence of verapamil for the treatment of superficial bladder cancer: preliminary report of a collaborative study. Cancer Chemother Pharmacol (1992) 0.82
Intravesical chemotherapy in the United States. An overview. Cancer Chemother Pharmacol (1983) 0.80
Intravesical combination chemotherapy with mitomycin C and doxorubicin for superficial bladder cancer: a randomized trial of maintenance versus no maintenance following a complete response. Cancer Chemother Pharmacol (1992) 0.77
Bladder instillation of adriamycin in the treatment of bladder cancer. Cancer Chemother Pharmacol (1983) 0.76
Development and clinical application of an AFC regimen (adriamycin, futraful, cytosine arabinoside) for superficial bladder tumors. Cancer Chemother Pharmacol (1983) 0.75
Sequential instillation therapy with mitomycin C and adriamycin for superficial bladder tumors. Cancer Chemother Pharmacol (1987) 0.75
Minimization of inflammation in the treatment of bladder tumors by intravesical instillation of adriamycin. Cancer Chemother Pharmacol (1983) 0.75
Intravesical chemotherapy. Cancer Chemother Pharmacol (1987) 0.75
Molecular cloning and characterization of a surface antigen preferentially overexpressed on multiple myeloma cells. Biochem Biophys Res Commun (1999) 3.03
The Crow-Fukase syndrome: a study of 102 cases in Japan. Neurology (1984) 2.65
Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum. J Biochem (1997) 2.51
Clinical features of a new disease concept, IgG4-related thyroiditis. Scand J Rheumatol (2013) 2.05
Correlation of tissue and plasma RANTES levels with disease course in patients with breast or cervical cancer. Clin Cancer Res (2001) 1.79
Enhanced resistance of mice to bacterial infection induced by recombinant human interleukin-1a. Infect Immun (1987) 1.69
The Fate of Micrococcus Aureus introduced into the Blood Stream of Dogs. J Med Res (1917) 1.52
Factor XII but not protein C, protein S, antithrombin III, or factor XIII is a predictor of recurrent miscarriage. Fertil Steril (2001) 1.44
Sphingosine 1-phosphate as a major bioactive lysophospholipid that is released from platelets and interacts with endothelial cells. Blood (2000) 1.44
Super high resolution for single molecule-sequence-based typing of classical HLA loci at the 8-digit level using next generation sequencers. Tissue Antigens (2012) 1.44
Utility of duplex Doppler ultrasound in evaluating portal hypertension in children. J Pediatr Gastroenterol Nutr (1995) 1.40
Endothelin-A receptor mediates cardiac inhibition by regulating calcium and potassium currents. Nature (1994) 1.37
Studies on the structure of water using two-dimensional near-infrared correlation spectroscopy and principal component analysis. Anal Chem (2001) 1.35
Interferons and indoleamine 2,3-dioxygenase: role in antimicrobial and antitumor effects. Experientia (1989) 1.33
IgE class-specific suppressor T cells and factors in humans. J Immunol (1983) 1.31
Lactobacillus reuteri in bovine milk fermented decreases the oral carriage of mutans streptococci. Int J Food Microbiol (2004) 1.31
Sphingosine 1-phosphate: synthesis and release. Prostaglandins Other Lipid Mediat (2001) 1.29
Role of Fc receptor gamma-chain in platelet glycoprotein Ib-mediated signaling. Blood (2001) 1.28
Metabolism and functional effects of sphingolipids in blood cells. Br J Haematol (1999) 1.24
Generation of the topa quinone cofactor in bacterial monoamine oxidase by cupric ion-dependent autooxidation of a specific tyrosyl residue. FEBS Lett (1994) 1.24
Changes in bacterial phagocytosis of macrophages in experimental ulcerative colitis. Digestion (1995) 1.22
Amino acid sequence of a purothionin homolog from barley flour. J Biochem (1980) 1.21
Phenytoin-induced orofacial dyskinesia. A case report. J Neurol (1985) 1.19
Novel platelet activation receptor CLEC-2: from discovery to prospects. J Thromb Haemost (2011) 1.18
Treatment of node-positive endometrial cancer with complete node dissection, chemotherapy and radiation therapy. Br J Cancer (1997) 1.18
Aspirin resistance detected with aggregometry cannot be explained by cyclooxygenase activity: involvement of other signaling pathway(s) in cardiovascular events of aspirin-treated patients. J Thromb Haemost (2006) 1.17
The actions of interferon and antiinflammatory agents of induction of indoleamine 2,3-dioxygenase in human peripheral blood monocytes. Biochem Biophys Res Commun (1987) 1.17
Humanized anti-HM1.24 antibody mediates myeloma cell cytotoxicity that is enhanced by cytokine stimulation of effector cells. Blood (1999) 1.14
Two-dimensional visible/near-infrared correlation spectroscopy study of thermal treatment of chicken meats. J Agric Food Chem (2000) 1.10
A selective medium for isolation and presumptive identification of the Bacteriodes fragilis group. Microbiol Immunol (1983) 1.09
Implications of interferon-induced tryptophan catabolism in cancer, auto-immune diseases and AIDS. Adv Exp Med Biol (1991) 1.08
Ischemia-related lesion characteristics in patients with stable or unstable angina. A study with intracoronary angioscopy and ultrasound. Circulation (1995) 1.07
Comparative validation of quantitative coronary angiography systems. Results and implications from a multicenter study using a standardized approach. Circulation (1995) 1.05
Glycoprotein Ib-von Willebrand factor interactions activate tyrosine kinases in human platelets. Blood (1997) 1.03
Intravesical adriamycin chemotherapy in bladder cancer. Cancer Chemother Pharmacol (1983) 1.02
G(i)-mediated Cas tyrosine phosphorylation in vascular endothelial cells stimulated with sphingosine 1-phosphate: possible involvement in cell motility enhancement in cooperation with Rho-mediated pathways. J Biol Chem (2000) 1.01
Simultaneous determination of uric and ascorbic acids in human serum by reversed-phase high-performance liquid chromatography with electrochemical detection. Anal Biochem (1984) 1.01
Sphingosine 1-phosphate induces sinus tachycardia and coronary vasoconstriction in the canine heart. Cardiovasc Res (2000) 1.01
Melatonin in rat pineal, plasma, and urine: 24-hour rhythmicity and effect of chlorpromazine. Endocrinology (1976) 1.01
Intravesical chemotherapy with 4'-epi-Adriamycin in patients with superficial bladder tumors. Cancer Chemother Pharmacol (1986) 1.00
Studies on the neutralization of Japanese encephalitis virus. I. Application of kinetic neutralization to the measurement of the neutralizing potency of antiserum. J Immunol (1967) 0.99
FT-IR and near-infrared FT-Raman studies of the secondary structure of insulinotropin in the solid state: alpha-helix to beta-sheet conversion induced by phenol and/or by high shear force. J Pharm Sci (1994) 0.98
Biotyping of Propionibacterium acnes isolated from normal human facial skin. Appl Environ Microbiol (1979) 0.97
Analgesic component of Notopterygium incisum Ting. Chem Pharm Bull (Tokyo) (1993) 0.97
Involvement of dendritic cells in sarcoidosis. Thorax (2004) 0.96
Antiinflammatory effect of Graptophyllum pictum (L.) Griff. Chem Pharm Bull (Tokyo) (1989) 0.96
Expression of immediate early genes and vasopressin heteronuclear RNA in the paraventricular and supraoptic nuclei of rats after acute osmotic stimulus. J Neuroendocrinol (2005) 0.95
Effects of polyions on Japanese encephalitis virus: difference in interaction of virus with DEAE dextran and dextran sulfate between PS cell adapted and non-adapted virus. Arch Gesamte Virusforsch (1972) 0.95
Acetic, propionic, and oleic acid as the possible factors influencing the predominant residence of some species of Propionibacterium and coagulase-negative Staphylococcus on normal human skin. Can J Microbiol (1984) 0.94
Cofactor activity of dihydroflavin mononucleotide and tetrahydrobiopterin for murine epididymal indoleamine 2,3-dioxygenase. Biochem Biophys Res Commun (1986) 0.94
Proteolytic processing of nuclear factor kappa B by calpain in vitro. FEBS Lett (1996) 0.93
Long-term ingestion of lactosucrose increases Bifidobacterium sp. in human fecal flora. Digestion (1995) 0.93
Involvement of Hic-5 in platelet activation: integrin alphaIIbbeta3-dependent tyrosine phosphorylation and association with proline-rich tyrosine kinase 2. Biochem J (2001) 0.92
Platelet activation markers and soluble adhesion molecules in patients with systemic lupus erythematosus. Autoimmunity (2001) 0.92
Utilization of dihydroflavin mononucleotide and superoxide anion for the decyclization of L-tryptophan by murine epididymal indoleamine 2,3-dioxygenase. Arch Biochem Biophys (1987) 0.91
Emphysematous pyelonephritis- conversion of type i to type II appearance on serial CT studies. Clin Imaging (2000) 0.91
Experimental validation of geometric and densitometric coronary measurements on the new generation Cardiovascular Angiography Analysis System (CAAS II). Cathet Cardiovasc Diagn (1993) 0.91
Augmentation of host resistance to microbial infections by recombinant human interleukin-1 alpha. Infect Immun (1988) 0.90
Vibrational spectra of scissile bonds in enzyme active sites: a resonance Raman study of dithioacylpapains. Biochemistry (1982) 0.90
Clinical significance of HLA-DRB1*0410 in Japanese patients with idiopathic thrombocytopenic purpura. Blood (1998) 0.90
Interferon gamma induced production of indoleamine 2,3 dioxygenase in cultured human synovial cells. J Rheumatol (1994) 0.90
Hypoglycemic effect of extracts from Lagerstroemia speciosa L. leaves in genetically diabetic KK-AY mice. Biosci Biotechnol Biochem (1996) 0.89
Gonadotropins and cytokines affect luteal function through control of apoptosis in human luteinized granulosa cells. J Clin Endocrinol Metab (2000) 0.89
Near-infrared Fourier transform Raman spectroscopic study of cornea and sclera. Jpn J Ophthalmol (1994) 0.89
[Studies of platelet aggregation in six cases of EDTA-dependent pseudothrombocytopenia]. Rinsho Ketsueki (1994) 0.89
Quantitative assessment with intracoronary ultrasound of the mechanisms of restenosis after percutaneous transluminal coronary angioplasty and directional coronary atherectomy. Am J Cardiol (1995) 0.89
Identification of lysophospholipid receptors in human platelets: the relation of two agonists, lysophosphatidic acid and sphingosine 1-phosphate. FEBS Lett (2000) 0.89
Studies on purothionin by chemical modifications. J Biochem (1982) 0.89
Cyclosporin A and phenytoin modulate inflammatory responses. J Dent Res (2009) 0.89
Quantification of the minimal luminal cross-sectional area after coronary stenting by two- and three-dimensional intravascular ultrasound versus edge detection and videodensitometry. Am J Cardiol (1996) 0.88
Short-wave near-infrared spectroscopy of biological fluids. 1. Quantitative analysis of fat, protein, and lactose in raw milk by partial least-squares regression and band assignment. Anal Chem (2001) 0.88
Differential activation and redistribution of c-Src and Fyn in platelets, assessed by MoAb specific for C-terminal tyrosine-dephosphorylated c-Src and Fyn. Biochim Biophys Acta (2000) 0.88
Effects of sphingosine 1-phosphate, a naturally occurring biologically active lysophospholipid, on the rat cardiovascular system. Jpn J Pharmacol (2000) 0.88
The effects of chemotherapy including cisplatin on vitamin D metabolism. Endocr J (1993) 0.87
Intranuclear crystal formation of poliovirus: electron microscopic observations. Exp Mol Pathol (1969) 0.87
Copper/topa quinone-containing histamine oxidase from Arthrobacter globiformis. Molecular cloning and sequencing, overproduction of precursor enzyme, and generation of topa quinone cofactor. J Biol Chem (1995) 0.87
Biological activities of novel lipid mediator sphingosine 1-phosphate in rat hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol (2000) 0.87
Near-infrared spectroscopy for dairy management: measurement of unhomogenized milk composition. J Dairy Sci (1999) 0.87
FcgammaRII tyrosine phosphorylation differs between FcgammaRII cross-linking and platelet-activating anti-platelet monoclonal antibodies. Biochim Biophys Acta (1999) 0.86
The pH dependence of the resonance raman spectra and structural alterations at heme moieties of various c-type cytochromes. Biochim Biophys Acta (1977) 0.86
Selective and differential media for isolation and tentative identification of each species of Pityrosporum residing on normal or diseased human skin. Microbiol Immunol (1981) 0.86
Protein-tyrosine phosphorylation and p72syk activation in human platelets stimulated with collagen is dependent upon glycoprotein Ia/IIa and actin polymerization. Thromb Haemost (1996) 0.86
A role for glycosphingolipid-enriched microdomains in platelet glycoprotein Ib-mediated platelet activation. J Thromb Haemost (2007) 0.86
Synthesis of phosphatidylinositol 3,4-bisphosphate but not phosphatidylinositol 3,4,5-trisphosphate is closely correlated with protein-tyrosine phosphorylation in thrombin-activated human platelets. Biochem Biophys Res Commun (1992) 0.85
Anti-platelet action of isoliquiritigenin, an aldose reductase inhibitor in licorice. Eur J Pharmacol (1992) 0.85
Signal transduction pathways mediated by glycoprotein Ia/IIa in human platelets: comparison with those of glycoprotein VI. Biochem Biophys Res Commun (1999) 0.85
Phagocytosis in Vivo under various Conditions. J Med Res (1917) 0.85
Bacterial invasion into the colonic mucosa in ulcerative colitis. J Gastroenterol Hepatol (1993) 0.85
Tyrosine phosphorylation and p72syk activation by an anti-glycoprotein Ib monoclonal antibody. Blood (1997) 0.85
Excitation wavelength-dependent changes in Raman spectra of whole blood and hemoglobin: comparison of the spectra with 514.5-, 720-, and 1064-nm excitation. J Biomed Opt (2001) 0.85
Usefulness of MR venography in diagnosing sinus pericranii: case report. Radiat Med (2001) 0.85
Wheat germ agglutinin-induced platelet activation via platelet endothelial cell adhesion molecule-1: involvement of rapid phospholipase C gamma 2 activation by Src family kinases. Biochemistry (2001) 0.84
Presence of melatonin in plasma and urine or pinealectomized rats. Endocrinology (1976) 0.84